Composition
- Active ingredients
- LINAGLIPTIN 5MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LINAGLIPTIN 5MG · TabletANDA208448-001 · Prescription
- LINAGLIPTIN 5MG · TabletANDA208335-001 · Prescription
- LINAGLIPTIN 5MG · TabletThis page
- LINAGLIPTIN 5MG · TabletANDA208428-001 · Prescription
- LINAGLIPTIN 5MG · TabletANDA208415-001 · Prescription
- LINAGLIPTIN 5MG · TabletANDA208431-001 · Prescription
- LINAGLIPTIN 5MG · TabletANDA208457-001 · Prescription
- LINAGLIPTIN 5MG · TabletANDA208433-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA208423.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Linagliptin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Invagen Pharms
- Status
- Prescription
- FDA approval
- 3 Sept 2024
- Application
- ANDA208423-001